Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.


Schorn S., Vogel T., Demir I., Demir E., Safak O., Friess H., ...More

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], vol.20, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20
  • Publication Date: 2020
  • Doi Number: 10.1016/j.pan.2020.10.043
  • Title of Journal : Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Abstract

Objective: Postoperative pancreatic fistula/POPF is the most feared complication in pancreatic surgery. Although several systematic reviews investigated the impact of somatostatin analogues on POPF, no stratification was performed regarding type of pancreatic resection (pancreaticoduodenectomy/PD; distal pancreatectomy/DP) and different somatostatin analogues.